| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Anavex Life Sciences Corp (F: 12X1)
12X1 Technical Analysis
5
| As on 14th Nov 2025 12X1 STOCK Price closed @ 3.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.54 & Strong Sell for SHORT-TERM with Stoploss of 4.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
12X1STOCK Price
| Open | 4.90 | Change | Price | % |
| High | 4.90 | 1 Day | -1.98 | -38.60 |
| Low | 2.26 | 1 Week | -3.24 | -50.70 |
| Close | 3.15 | 1 Month | -4.10 | -56.55 |
| Volume | 6025 | 1 Year | -1.18 | -27.25 |
| 52 Week High 12.63 | 52 Week Low 3.33 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| 12X1 Daily Charts |
12X1 Intraday Charts |
Whats New @ Bazaartrend |
12X1 Free Analysis |
|
|
12X1 Important Levels Intraday
| RESISTANCE | 8.24 |
| RESISTANCE | 6.61 |
| RESISTANCE | 5.60 |
| RESISTANCE | 4.59 |
| SUPPORT | 1.71 |
| SUPPORT | 0.70 |
| SUPPORT | -0.31 |
| SUPPORT | -1.94 |
12X1 Forecast November 2025
| 4th UP Forecast | 7 |
| 3rd UP Forecast | 5.77 |
| 2nd UP Forecast | 5 |
| 1st UP Forecast | 4.24 |
| 1st DOWN Forecast | 2.06 |
| 2nd DOWN Forecast | 1.3 |
| 3rd DOWN Forecast | 0.53 |
| 4th DOWN Forecast | -0.7 |
12X1 Weekly Forecast
| 4th UP Forecast | 4.11 |
| 3rd UP Forecast | 3.80 |
| 2nd UP Forecast | 3.61 |
| 1st UP Forecast | 3.42 |
| 1st DOWN Forecast | 2.88 |
| 2nd DOWN Forecast | 2.69 |
| 3rd DOWN Forecast | 2.50 |
| 4th DOWN Forecast | 2.19 |
12X1 Forecast2025
| 4th UP Forecast | 24.33 |
| 3rd UP Forecast | 17.54 |
| 2nd UP Forecast | 13.34 |
| 1st UP Forecast | 9.14 |
| 1st DOWN Forecast | -2.84 |
| 2nd DOWN Forecast | -7.04 |
| 3rd DOWN Forecast | -11.24 |
| 4th DOWN Forecast | -18.03 |
Anavex Life Sciences Corp ( F Germany Symbol : 12X1 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
12X1 Business Profile
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials to treat Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company is based in New York, New York. Address: 51 West 52nd Street, New York, NY, United States, 10019
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service